2 weeks Ago By ABMN Staff
Hsbc Holdings PLC reduced its holdings in Innospec Inc. ( NASDAQ:IOSP – Free Report ) by 1.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission.
The fund owned 8,502 shares of the specialty chemicals company’s stock after selling 115 shares during the quarter. Hsbc Holdings PLC’s holdings in Innospec were worth $1,056,000 as of its most recent filing with the Securities and Exchange Commission. Several other large investors have also recently added to or reduced their stakes in the business.
TFO Wealth Partners LLC grew its holdings in Innospec by 29,800.0% in the 4th quarter. TFO Wealth Partners LLC now owns 299 shares of the specialty chemicals company’s stock valued at $37,000 after buying an additional 298 shares during the period.
DekaBank Deutsche Girozentrale acquired a new stake in shares of Innospec in the first quarter worth approximately $66,000. CWM LLC grew its holdings in Innospec by 239.6% in the second quarter.
CWM LLC now owns 635 shares of the specialty chemicals company’s stock valued at $78,000 after purchasing an additional 448 shares during the period. Motco acquired a new position in Innospec during the first quarter worth approximately $132,000. Finally, EntryPoint Capital LLC purchased a new position in Innospec during the first quarter worth approximately $147,000.
96.64% of the stock is currently owned by hedge funds and other institutional investors. Analyst Upgrades and Downgrades Separately, StockNews.
com cut shares of Innospec from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 8th. Insider Activity In related news, CFO Ian Cleminson sold 6,602 shares of Innospec stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $113.
60, for a total transaction of $749,987.20. Following the transaction, the chief financial officer now owns 16,394 shares in the company, valued at approximately $1,862,358.
40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink . Insiders own 1.
52% of the company’s stock. Innospec Price Performance Shares of NASDAQ:IOSP opened at $114.09 on Friday.
The business has a 50-day moving average of $114.25 and a two-hundred day moving average of $121.37.
The firm has a market capitalization of $2.85 billion, a PE ratio of 19.37 and a beta of 1.
08. Innospec Inc. has a 12 month low of $95.
69 and a 12 month high of $133.71. Innospec ( NASDAQ:IOSP – Get Free Report ) last posted its earnings results on Tuesday, August 6th.
The specialty chemicals company reported $1.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.37 by $0.
02. The firm had revenue of $435.00 million during the quarter, compared to the consensus estimate of $468.
73 million. Innospec had a net margin of 7.90% and a return on equity of 14.
15%. The company’s revenue was down 9.5% on a year-over-year basis.
During the same quarter in the prior year, the company earned $1.28 EPS. As a group, research analysts anticipate that Innospec Inc.
will post 5.95 earnings per share for the current year. Innospec Company Profile ( Free Report ) Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally.
The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels. See Also Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc.
( NASDAQ:IOSP – Free Report ). Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter .
.
